ClinicalTrials.gg
RecruitingNCT07103707Updated Aug 5, 2025

Comparison of Frequency of Wound Infection Between Open and Laparoscopic Cholecystectomy

An interventional study of open cholecystectomy and Laparoscopic cholecystectomy in Wound Infection, Surgical, sponsored by Lady Reading Hospital, Pakistan. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-05.

Sponsored by Lady Reading Hospital, Pakistan · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
122
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the frequency of wound infection between open and laparoscopic cholecystectomy in adult patient aged 18- 65 years with symptomatic cholelithiasis admitted through OPD the main question it aims to answer are

  • Does there is difference in the frequency of wound infection in patients with open cholecystectomy as compared to laparoscopic cholecystectomy Researcher will compare the frequency of wound infection in participant undergoing open and laparoscopic cholecystectomy to see there is difference in frequency of wound infection between open and laparoscopic cholecystectomy Participants will be asked
  • To Visit OPD after 1 week for follow up
  • Keep record of symptoms like erythema, pain, cloudy drainage from the incision site
02

Conditions studied

  • Wound Infection, Surgical
03

In context

Surgical Wound Infection

745 studies on the registry are indexed under Surgical Wound Infection; 151 are open to participants now.

This study's planned enrollment of 122 is below the median of 200 across 581 interventional studies indexed under Surgical Wound Infection.

Browse Surgical Wound Infection studies →

Lead sponsor

Lady Reading Hospital, Pakistan is the lead sponsor of 13 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Both genders

    • Patients aged 18 to 65 years
    • Symptomatic cholelithiasis as per operational definition
    • Undergoing cholecystectomy (open/laparoscopic)
    • I/II (Annexure-II)

Exclusion criteria

Exclusion Criteria:

  • ● H/o diabetes mellitus

    • H/o state (e.g. , use)
    • H/o acute cholecystitis
    • H/o empyema gallbladder
    • H/o gallbladder perforation ● H/o choledocholithiasis
    • H/o portal hypertension
    • H/o abnormal blood clotting profiles ( >15 seconds, APTT >20 seconds)
    • H/o pregnancy on HCG
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

INR, PT and aPTT (clotting tests)

Blood tests of how long blood takes to clot. The INR is the prothrombin time (PT) put on a common scale; about 1 is usual for someone not taking a blood thinner.

Criteria often make an exception for people on a blood thinner such as warfarin, whose INR is raised on purpose.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
122 participants (estimated)

Study arms

  • Active comparator
    open cholecystectomy

    patient undergoing open cholecystectomy

    Procedure: open cholecystectomy

  • Active comparator
    laparoscopic cholecystectomy

    patient undergoing laparoscopic cholecystectomy

    Procedure: Laparoscopic cholecystectomy

Interventions

  • Procedureopen cholecystectomy

    standard open cholecystectomy performed under general anesthesia

  • ProcedureLaparoscopic cholecystectomy

    Standard laparoscopic cholecystectomy using minimally invasive technique

06

What researchers measure

Primary outcomes

  1. comparison of frequency of wound infection between open and laparoscopic cholecystectomy

    to compare the frequency of wound infection in patients undergoing open and laparoscopic

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Moeez u din khan
    Peshawar, Khyber Pakhtunkhwa 25000, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07103707
Lead sponsor
Lady Reading Hospital, Pakistan
Responsible party
Moeez u din Khan (surgical resident, Lady Reading Hospital, Pakistan) — Principal investigator
First posted
Aug 5, 2025
Start date
Aug 2025 (estimated)
Primary completion
Aug 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Aug 5, 2025

Study contacts

Moeez u din khan, PGR GS
Contact
moeezk442@gmail.com
+923489548857
IJAZ UL HAQUE, PGR NS
Contact
drijazulhaque712237@gmail.com
+923499223911
Ahmad faraz, AP GS(FCPS)
principal investigator · Lady reading hospital peshawar

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion